To: AlienTech who wrote (5778 ) 3/7/1998 2:46:00 PM From: Jenna Read Replies (4) | Respond to
RXSD..another viewpoint. RXSD is the Nol 1 selling vitamin line in the U.S. It's headquarters are 2 miles from my home. (but that's not the only reason I like it) RXSD has a deteriorating technical chart on that score I am in total agreement. It's MACD is bearish as is its 10 and 20 day moving average. RXSD' fundamental chart is in the top 1% of companies. It has had 4 surprises in the last 4 quarters and its ERG is a whopping 99 and EPS rank 98.. Growth is high projected forward for next 3 quarters. But RXSD was on an uptrend from the day it's earnings and went from 26 to 38 without stopping for a breather. It's EPS was revised upwards for next 2 quarters and next fiscal year although it was slightly down for the upcoming reporting quarter, but that was after it was revised upward quite a bit after last quarter's report. It's overextended but should pull back and provide another good play as it has in the last 3 quarters that I've played it for earnings. I am waiting for a decent pullback until earnings come out on March 18, 1998 and the stocks breaks resistance and its 38.62 52 week high.
